Company profile for AUM LifeTech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform in the gene silencing and regulation space. Our mission is to leverage the power and adaptability of our unique FANA ASO RNA silencing technology to treat and find a cure some for genetically defined diseases. In order to do so, our technology relies on one of the most important molecules in the body: RNA. AUM LifeTech’s FA...
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform in the gene silencing and regulation space. Our mission is to leverage the power and adaptability of our unique FANA ASO RNA silencing technology to treat and find a cure some for genetically defined diseases. In order to do so, our technology relies on one of the most important molecules in the body: RNA. AUM LifeTech’s FANA ASO RNA silencing technology holds the key to successful development of Nucleic Acid Therapeutics. Our goal is to successfully address some of the challenges in therapeutic development using our next-generation

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3675 Market Street, Suite 200 Philadelphia, PA – 19104
Telephone
Telephone
+1-215-501-7152
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/philadelphia-based-biotech-company-aum-lifetech-awarded-400-000-ncinih-grant-to-advance-their-lung-cancer-immunotherapy-program-using-rna-targeting-gene-therapy-with-checkpoint-inhibitors-301607675.html

PRNEWSWIRE
17 Aug 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty